Founded in 2013 by Dr. Denis Dufrane and Dr. Jean-François Pollet, Novadip Biosciences is a spin-off from the University of Louvain (UCLouvain) and Saint-Luc University Clinics focusing on regenerative medicine . The creation of Novadip Biosciences was supported by the Louvain Technology Transfer Office (LTTO), Sopartec and VIVES II.

While Novadip's first mission was to treat patients with bone defects and bone diseases, its innovative fat cell technology offers potential for other applications, including skin regeneration. These therapies solve the real problems faced by physicians and patients around the world and aim for more positive clinical outcomes and a long-term quality of life.